Clinical trial

ZD 1839 Plus Combination Chemotherapy in Treating Patients With Non-Small Cell Lung Cancer

NCT00006048

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2000-05-01

PhasePHASE3

Study timeline

Study start (unknown)2000-05-01Date precision: month

Registry last updated2013-12-19

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Lung Cancerunresolved

Interventions

cisplatinDRUG · verified · RxNorm: cisplatin

gefitinibDRUG · verified · RxNorm: gefitinib

gemcitabine hydrochlorideDRUG · verified · RxNorm: gemcitabine hydrochloride

Sponsors & collaborators

AstraZenecalead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00006048 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.